Suppr超能文献

特发性肺纤维化的基质生物学:美国国立心肺血液研究所研讨会报告

Matrix biology of idiopathic pulmonary fibrosis: a workshop report of the national heart, lung, and blood institute.

作者信息

Thannickal Victor J, Henke Craig A, Horowitz Jeffrey C, Noble Paul W, Roman Jesse, Sime Patricia J, Zhou Yong, Wells Rebecca G, White Eric S, Tschumperlin Daniel J

机构信息

Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.

Department of Medicine, University of Minnesota, Minneapolis, Minnesota.

出版信息

Am J Pathol. 2014 Jun;184(6):1643-51. doi: 10.1016/j.ajpath.2014.02.003. Epub 2014 Apr 13.

Abstract

A hallmark of idiopathic pulmonary fibrosis (IPF) is excessive and disordered deposition of extracellular matrix. Although the lung extracellular matrix normally plays an essential role in development and maintenance of lung tissue through reciprocal interactions with resident cells, the disordered matrix in the diseased lung is increasingly recognized as an active and important contributor to IPF pathogenesis. This working group summary from a recently conducted National Heart, Lung, and Blood Institute strategic planning workshop for IPF research highlights recent advances, challenges, and opportunities in the study of matrix biology in IPF. Particular attention is given to the composition and mechanical properties of the matrix in normal and diseased lungs, and the biochemical and biomechanical influences exerted by pathological matrix. Recently developed model systems are also summarized as key tools for advancing our understanding of matrix biology in IPF. Emerging approaches to therapeutically target the matrix in preclinical and clinical settings are discussed, as are important concepts, such as alterations of the matrix with aging and the potential for the resolution of fibrosis. Specific recommendations for future studies in matrix biology of IPF are also proposed.

摘要

特发性肺纤维化(IPF)的一个标志是细胞外基质过度且无序沉积。尽管肺细胞外基质通常通过与驻留细胞的相互作用在肺组织的发育和维持中发挥重要作用,但患病肺中无序的基质越来越被认为是IPF发病机制的一个积极且重要的促成因素。这份来自美国国立心肺血液研究所最近为IPF研究举办的战略规划研讨会的工作组总结,重点介绍了IPF基质生物学研究的最新进展、挑战和机遇。特别关注正常和患病肺中基质的组成和力学性质,以及病理基质所施加的生化和生物力学影响。最近开发的模型系统也被总结为推进我们对IPF基质生物学理解的关键工具。讨论了在临床前和临床环境中针对基质进行治疗的新兴方法,以及一些重要概念,如基质随衰老的变化和纤维化消退的可能性。还提出了IPF基质生物学未来研究的具体建议。

相似文献

3
Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis.肺成纤维细胞、衰老与特发性肺纤维化
Ann Am Thorac Soc. 2016 Dec;13 Suppl 5:S417-S421. doi: 10.1513/AnnalsATS.201605-341AW.
4
Cartilage oligomeric matrix protein in idiopathic pulmonary fibrosis.特发性肺纤维化中的软骨寡聚基质蛋白。
PLoS One. 2013 Dec 20;8(12):e83120. doi: 10.1371/journal.pone.0083120. eCollection 2013.
5
Pathogenesis of idiopathic pulmonary fibrosis.特发性肺纤维化的发病机制。
Annu Rev Pathol. 2014;9:157-79. doi: 10.1146/annurev-pathol-012513-104706. Epub 2013 Sep 13.
6
Mechanistic links between aging and lung fibrosis.衰老与肺纤维化之间的机制联系。
Biogerontology. 2013 Dec;14(6):609-15. doi: 10.1007/s10522-013-9451-6. Epub 2013 Aug 9.

引用本文的文献

2
The use of mechanical ventilation in interstitial lung disease.机械通气在间质性肺疾病中的应用。
Breathe (Sheff). 2025 Apr 17;21(2):240172. doi: 10.1183/20734735.0172-2024. eCollection 2025 Apr.
7
Bioimpedance measurements of fibrotic and acutely injured lung tissues.纤维化和急性损伤肺组织的生物电阻抗测量。
Acta Biomater. 2025 Mar 1;194:270-287. doi: 10.1016/j.actbio.2025.01.039. Epub 2025 Jan 25.
10
Emerging delivery approaches for targeted pulmonary fibrosis treatment.靶向肺纤维化治疗的新兴给药途径。
Adv Drug Deliv Rev. 2024 Jan;204:115147. doi: 10.1016/j.addr.2023.115147. Epub 2023 Dec 6.

本文引用的文献

3
Host responses in tissue repair and fibrosis.组织修复和纤维化中的宿主反应。
Annu Rev Pathol. 2013 Jan 24;8:241-76. doi: 10.1146/annurev-pathol-020712-163930. Epub 2012 Oct 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验